Skip to main content
    M

    MetLife Inc (MET)

    Official site

    FINANCIAL SERVICES • INSURANCE - LIFE • NYSE

    $101.53
    +0.07 (+0.07%)

    Market Cap: $64.51B

    Last updated: Nov 17, 2026 at 4:30 PM ET

    MetLife Inc (MET) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    MetLife (MET) has a market cap of $64.51B. Its share count is down 4.62% from a year earlier.

    Total Valuation

    Market Cap$64.51B
    Latest price (Nov 17, 2026)$101.53

    Key Dates

    The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 3, 2026.

    Next Earnings DateFeb 2, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Last Ex-Dividend DateNov 3, 2026
    Next Payment DateDec 8, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.11% in the quarter ended Sep 30, 2026 and shrank 4.73% a year over 2 years.

    Shares Outstanding628.44M
    Shares Change (YoY)-4.62%
    Shares Change (QoQ)-1.11%
    Share Count Growth (2Y CAGR)-4.73%

    Valuation Ratios

    Sales and book value multiples are 0.8x and 2.9x. Its year-end P/E ranged from 6.9x to 11.7x from 2016 to 2025.

    P/E Ratio10.0x
    Forward P/E9.8x
    P/S Ratio0.8x
    Forward P/S0.8x
    P/B Ratio2.9x
    P/TBV Ratio5.0x
    P/OCF Ratio4.6x
    PEG Ratio0.9

    Valuation history and multiples

    Price Statistics

    The stock is up 30.05% over 52 weeks and trades 3.09% above its 50-day average.

    Beta (1Y)0.63
    52-Week Change+30.05%
    1-Month Change+2.55%
    3-Month Change+7.37%
    6-Month Change+26.00%
    5-Year Change+59.27%
    10-Year Change+112.99%
    Total Return (1Y)+33.06%
    Total Return (3Y CAGR)+19.84%
    Total Return (5Y CAGR)+12.85%
    Return vs SPY (1Y)+24.14%
    Max Drawdown (1Y)-18.56%
    Max Drawdown (3Y)-22.14%
    Sharpe Ratio (1Y)1.30
    Correlation with SPY (1Y)0.37
    50-Day Average$98.49
    200-Day Average$86.43
    52-Week Range$66.02 to $106.72
    RSI (14 Days)54.0
    Average Volume (20 Days)3.30M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Returns and Efficiency

    Return on equity is 23.26% over the last 12 months, against a 5-year average of 12.29%.

    Return on Equity (ROE)23.26%
    Return on Assets (ROA)0.69%
    ROE (5Y Average)12.29%
    ROA (5Y Average)0.61%
    Asset Turnover0.11x

    Taxes

    Income tax took 22.38% of pretax income over the last 12 months.

    Income Tax (TTM)$1.49B
    Effective Tax Rate22.38%

    Scores

    MET has a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $83.27B over the last 12 months is up 15.62% from the 12 months before.

    Revenue$83.27B
    Revenue Growth (YoY)+15.62%
    Pretax Income$6.66B
    Net Income$5.17B
    Reported EPS (TTM)$10.19

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 2.99% of the $744.61B in total assets.

    Shareholder Equity$22.23B
    Book Value Per Share$35.37
    Tangible Book Value$12.68B
    Tangible Book Per Share$20.18
    Cash and Equivalents$19.79B
    Total Debt$40.43B
    Net Debt$20.64B
    Net Debt Per Share$32.85
    Total Assets$744.61B
    Total Liabilities$721.89B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow$13.99B
    FCF Per Share$22.17
    Dividends Paid$1.66B
    Share Repurchases$2.59B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    Pretax Margin8.00%
    Net Margin6.21%
    Operating Margin (5Y Average)7.95%
    Net Margin (5Y Average)6.07%

    Growth

    Revenue grew 2.31% a year over 3 years, and EPS 8.80% a year.

    Revenue Growth (3Y CAGR)+2.31%
    Revenue Growth (5Y CAGR)+2.72%
    EPS Growth (3Y CAGR)+8.80%
    EPS Growth (5Y CAGR)+7.38%
    FCF Growth (3Y CAGR)+9.43%
    FCF Growth (5Y CAGR)+18.32%
    Operating Income Growth (3Y CAGR)-9.86%
    Book Value Per Share Growth (2Y CAGR)+2.99%
    Tangible Book Per Share Growth (2Y CAGR)+0.67%

    Revenue and profit by year

    Dividends and Yields

    MET pays out 28.51% of earnings as dividends.

    Dividend Per Share (Annual)$2.37
    Dividend Yield2.33%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+4.31%
    Dividend Growth (5Y CAGR)+4.31%
    Payout Ratio28.51%
    Earnings Yield10.00%
    Buyback Yield4.06%
    Shareholder Yield6.42%

    Full dividend history

    Peer Position

    Against 11 similar companies, MET has the 9th highest P/E.

    P/E Ratio10.0x vs 11.7x median
    P/S Ratio0.8x vs 1.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)+15.62% vs +4.13% median
    Dividend Yield2.33% vs 2.33% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.45% and EPS growth at 12.66% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.45%
    EPS Growth Forecast (2Y CAGR)+12.66%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MET

    What is MET's market cap?

    MetLife has a market cap of $64.51B.

    What is MET's P/E ratio?

    MetLife has a trailing P/E ratio of 10.0x and a forward P/E of 9.8x.

    How many shares of MET are outstanding?

    MetLife has 628.44M shares outstanding. The count is down 4.62% from a year earlier.

    Does MET pay a dividend?

    Yes. MetLife pays $2.37 a share a year, a dividend yield of 2.33%.